Pioneering Research
Zyneyro is a biotech company founded by a group of scientists from the Department of Neuroscience at the University of Copenhagen, Denmark.
Building upon more than 20 years of pioneering research in neuronal transmission, we have identified a unique molecular scaffold. This breaktrough discovery enables us to create novel treatments specifically designed to target disorders driven by maladaptive neural plasticity.
Steen Søren Klysner
Chief Executive Officer
Andreas Toft Sørensen
Chief Scientific Officer & Co-Founder
Kenneth Lindegaard Madsen
Chief Development Officer & Co-Founder
Ulrik Gether
Scientific Advisor & Co-Founder
Kathrine Louise Jensen
Senior Scientist
Ida Buur Kanneworff
Industrial PhD Student
Marie Løth Topp
Scientist
Gith Noes-Holt
Senior Scientist
Marco Benjamin K. Kowenicki
Scientist & Technical Systems Lead
Raquel Comaposada Baró
Senior Scientist
Celine Rytter Andersen
Student Assistant